DOJ Backs AbbVie At 7th Circ. In 'Patent Thicket' Case
By Matthew Perlman · January 4, 2021, 6:33 PM EST
The U.S. Department of Justice has thrown its weight behind AbbVie at the Seventh Circuit as Humira buyers look to revive their suit accusing the drugmaker of employing a "patent thicket"...
To view the full article, register now.